Lung lymphoid neogenesis in cystic fibrosis: a model of adaptive responses to bacteria?

Sophie T. Gohy, Maha Z. Ladjemi, Charles Pilette

Source: Eur Respir J , 49 (4)  1700380; DOI: 10.1183/13993003.00380-2017
Journal Issue: April

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sophie T. Gohy, Maha Z. Ladjemi, Charles Pilette. Lung lymphoid neogenesis in cystic fibrosis: a model of adaptive responses to bacteria?. Eur Respir J , 49 (4)  1700380; DOI: 10.1183/13993003.00380-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
What damages the cystic fibrosis lung epithelium: host or microbe?
Source: Virtual Congress 2021 – Innate immunity and lung epithelial repair: what really happens?
Year: 2021


Inflammatory responses to individual organisms in the lungs of children with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more
Year: 2010

Epithelial cell regulation of immunity in cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012

IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021



Lung inflammation in cystic fibrosis: an overlooked therapeutic target?
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020


Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis
Source: Eur Respir J 2012; 39: 297-304
Year: 2012



Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis
Source: Eur Respir J , 49 (4)  1601873; DOI: 10.1183/13993003.01873-2016
Year: 2017



Intestinal organoids to model cystic fibrosis
Source: Eur Respir J, 54 (1) 1802379; 10.1183/13993003.02379-2018
Year: 2019



Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Altered composition of Innate lymphoid cells in BAL and blood of adult patients with cystic fibrosis towards ILC1
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Immune cell localization in different compartments of human end-stage cystic fibrosis lungs
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Regulation of immune cells in lung fibrosis: the reign of regnase-1?
Source: Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020
Year: 2021



Current concepts: host–pathogen interactions in cystic fibrosis airways disease
Source: Eur Respir Rev 2014; 23: 320-332
Year: 2014



LSC 2010 Abstract: Deficient innate immune antiviral response to infection with rhinoviruses in cystic fibrosis airway epithelial cells
Source: Annual Congress 2010 - Cystic fibrosis: new targets for therapy and impact of viral infections
Year: 2010

Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002